Analysis Orexo AB (0H19)
5/28/2024
Analysis of Orexo AB (0H19)
Orexo AB is showing some interesting technical indicators based on the provided data.1. RSI Indicator: The Relative Strength Index (RSI) is quite high, indicating that the stock may be overbought. This could suggest a potential reversal or correction in the price.
2. MACD Indicator: The Moving Average Convergence Divergence (MACD) is positive, with the MACD line above the signal line. This could indicate a bullish trend in the stock price.
3. Moving Averages: The stock price is above the Simple Moving Average (SMA), Exponential Moving Average (EMA), and Weighted Moving Average (WMA). This suggests a positive trend in the stock price.
Overall, based on the technical indicators, Orexo AB may be in a bullish phase in the short term. However, the high RSI value indicates a potential overbought situation, so investors should exercise caution and consider other factors before making investment decisions.
Earnings
The company's results for the most recent quarter, as of April 30, 2025, have not been provided at this time. The previous results from February 27, 2025, were handled by the Transfer Agent. The results from January 31, 2025, were released after hours. The results from October 31, 2024, were not provided at the time. The results from August 1, 2024, showed an earnings per share (EPS) estimate of 1.32.Main Statystic ðŸ§
The data provided includes financials, stock statistics, valuation metrics, stock price summary, and dividends and splits information for a specific company.In terms of financials, the company has strong operating cash flow and levered free cash flow, with a positive profit margin and healthy return on assets and equity. The balance sheet shows a decent current ratio, but a relatively high total debt to equity ratio. The income statement indicates significant revenue and EBITDA, with a good gross profit margin and diluted EPS.
Stock statistics reveal details about the company's shares, including short interest, trading volumes, insider and institutional ownership percentages, and key ratios like short ratio and float shares. Valuation metrics show the company's price-to-earnings ratios, enterprise value, market capitalization, and other key financial ratios.
The stock price summary provides information on the stock's performance, including beta, moving averages, and the range of prices over the past year. Dividends and splits data include details on dividend rates, payout ratios, dividend yields, and historical split information.
Income statement 💸
Here are the revenue figures for the company over the past four fiscal years:1. Fiscal Year 2023: Sales of $383,285,000,000
2. Fiscal Year 2022: Sales of $394,328,000,000
3. Fiscal Year 2021: Sales of $365,817,000,000
4. Fiscal Year 2020: Sales of $274,515,000,000
From these figures, we can observe the following trends:
- The company experienced a decrease in sales from FY 2022 to FY 2023.
- Prior to that, there was an increase in sales from FY 2021 to FY 2022.
- The highest sales figure was recorded in FY 2022.
- There was a significant increase in sales from FY 2020 to FY 2021.
These trends indicate fluctuations in the company's revenue over the past four years, with both increases and decreases in sales figures.
Balance Sheet
These are balance sheets. Here are the conclusions:1. The total assets have been increasing over the years, reaching $365,725,000,000 in 2018.
2. Current assets fluctuate, with the highest value in 2019 at $162,819,000,000.
3. Non-current assets have been increasing steadily, with the highest value in 2019 at $175,697,000,000.
4. Total liabilities have also been increasing, reaching $290,437,000,000 in 2023.
5. Shareholders' equity has been fluctuating, with the highest value in 2018 at $107,147,000,000.
Cash Flow 💶
This is the cash flow statement. Here are some conclusions we can draw from the data:1. The company's free cash flow has been fluctuating over the years, with the highest value in 2022 and the lowest in 2020.
2. Operating cash flow has generally been increasing year over year, indicating improved operational efficiency.
3. The company has been consistently paying interest and income taxes, with varying amounts each year.
4. The end cash position has also been fluctuating, reaching its highest value in 2020.
5. Financing activities show a pattern of common stock repurchase, issuance of long-term debt, and payment of dividends.
6. Investing activities include the sale and purchase of investments, as well as capital expenditures.
7. Overall, the company seems to be managing its cash flow effectively, with a focus on operational efficiency and strategic investments.
Earnings estimate
Based on the analysts' estimates for future quarterly and annual earnings per share:1. For the current quarter ending on June 30, 2024, the average EPS estimate is $1.33, with a range from $1.27 to $1.36. This shows growth compared to the EPS of $1.26 from a year ago.
2. For the next quarter ending on September 30, 2024, the average EPS estimate is higher at $1.53, with a range from $1.44 to $1.63. This is also an improvement from the EPS of $1.46 from a year ago.
3. Looking at the current fiscal year ending on September 30, 2024, the average EPS estimate is $6.59, with a range from $6.43 to $6.92. This indicates growth compared to the EPS of $6.13 from the previous year.
4. For the next fiscal year ending on September 30, 2025, the average EPS estimate is $7.23, with a range from $6.40 to $7.90. This forecast suggests an increase from the EPS of $6.59 reported for the previous year.
Overall, the analysts are predicting growth in earnings per share for both the upcoming quarters and the next fiscal years, indicating positive expectations for the company's performance.
Revenue estimate
Based on the analysts' estimates for the future quarterly and annual sales of the company, we can draw the following conclusions:1. For the current quarter ending on June 30, 2024, the average sales estimate is $83,776,900,000, with a sales growth of 2% compared to the same quarter last year. The number of analysts providing estimates is 24.
2. For the next quarter ending on September 30, 2024, the average sales estimate is $92,375,300,000, with a sales growth of 3% compared to the same quarter last year. The number of analysts providing estimates is 24.
3. For the current fiscal year ending on September 30, 2024, the average sales estimate is $386,681,000,000, with a sales growth of 1% compared to the previous fiscal year. The number of analysts providing estimates is 37.
4. For the next fiscal year ending on September 30, 2025, the average sales estimate is $411,555,000,000, with a sales growth of 6% compared to the current fiscal year. The number of analysts providing estimates is 37.
These estimates suggest a moderate growth trend in both quarterly and annual sales for the company, with slightly higher growth expected in the next fiscal year compared to the current one.
Growth estimates
Based on the consensus estimates provided:- The company is expected to have a growth rate of 7.5% in the current year.
- The growth rate is projected to increase to 5.6% in the current quarter and further to 4.8% in the next quarter.
- Over the next year, the growth rate is expected to reach 9.7%.
- Looking ahead, the company is forecasted to have an annual growth rate of 11% over the next 5 years.
- However, when comparing to the past 5 years, where the company had an annual growth rate of 20.15%, the future growth rate is expected to be lower.
Overall, the company is expected to experience moderate growth in the near term, with a slightly higher growth rate in the next 5 years compared to the current and upcoming quarters.
Price target
The analysts' forecast for the future price of the security is as follows:- Low: $164
- High: $250
- Median: $200
- Average: $202.26
- Current price: $191.57
- Currency: USD
Based on these forecasts, we can see that the analysts have a range of opinions on the future price of the security, with the low end at $164, the high end at $250, and the average forecast at $202.26. The current price of the security is $191.57, which is below the median and average forecast, indicating that there is potential for growth according to the analysts' predictions.
MACD of 0H19
This is not investment advice. Remember to verify the information provided here.
Get access to the full analysis
- Over 35 000 indexes
- CFD, Forex, Crypto and Stocks Exchange
- Over 150 Indicators
- Pattern and candle analysis
- Support and resistance levels
- Fundamental, technical and sentimental analysis
- Power from AI
